Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Operating Expenses: 2024-2025

Historic Other Operating Expenses for KalVista Pharmaceuticals (KALV) over the last 2 years, with Apr 2025 value amounting to -$53.4 million.

  • KalVista Pharmaceuticals' Other Operating Expenses was N/A to -$9.6 million in Q1 2017 from the same period last year, while for Jan 2017 it was -$8.1 million, marking a year-over-year change of. This contributed to the annual value of -$53.4 million for FY2025, which is 49.25% down from last year.
  • KalVista Pharmaceuticals' Other Operating Expenses amounted to -$53.4 million in FY2025, which was down 49.25% from -$35.8 million recorded in FY2024.
  • In the past 5 years, KalVista Pharmaceuticals' Other Operating Expenses registered a high of -$35.8 million during FY2024, and its lowest value of -$53.4 million during FY2025.
  • Over the past 2 years, KalVista Pharmaceuticals' median Other Operating Expenses value was -$44.6 million (recorded in 2024), while the average stood at -$44.6 million.
  • Data for KalVista Pharmaceuticals' Other Operating Expenses shows a maximum YoY tumbled of 49.25% (in 2025) over the last 5 years.
  • Yearly analysis of 2 years shows KalVista Pharmaceuticals' Other Operating Expenses stood at -$35.8 million in 2024, then slumped by 49.25% to -$53.4 million in 2025.